SUN PHARMACEUTICAL INDUSTRIES INC 2026-06-17 Health serious FDA
Health · FDA · Recall #FDA-D-0607-2026
Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5… Recall
Issued June 17, 2026 · SUN PHARMACEUTICAL INDUSTRIES INC
In June 2026, SUN PHARMACEUTICAL INDUSTRIES INC recalled the Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution
What you should do
- 1 Stop using Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SUN PHARMACEUTICAL INDUSTRIES INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Health
- Recall date
- June 17, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0607-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- SUN PHARMACEUTICAL INDUSTRIES INC has 36 recalls in our database.
- We're tracking 3,673 Health recalls in our database.
- This is the 453rd Health recall we've logged in 2026.